Tag: Gene editing

Over two-thirds of the global population under 50 is estimated to be infected with the herpes simplex virus type 1 (HSV-1), which causes cold sores. While current treatments primarily manage symptoms, a new wave of innovative therapies and advanced research is redefining **what is the new treatment for cold sores**, moving beyond symptom management toward potential cures.

In a landmark decision in late 2023, the U.S. FDA approved Casgevy, the first treatment utilizing CRISPR technology to receive authorization. Understanding **how does casgevy gene therapy work** involves a look at its process of gene editing to enable a patient's body to produce healthy blood cells.